RSLBF (RaySearch Laboratories AB) Other Stockholders Equity: $111.9 Mil (As of Mar. 2026)


RSLBF RaySearch Laboratories AB RSLBF
90 GF Score
Price $24.00
GF Value $19.70
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Other Stockholders Equity?

RaySearch Laboratories AB RSLBF +13.37% 90 Other Stockholders Equity is $111.9 Mil as of Mar. 2026. GuruFocus rates RSLBF with a GF Score™ of 90/100 and a GF Value™ of $19.70 (Modestly Overvalued). The stock has 2 warning signs investors should review.

RaySearch Laboratories AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $111.9 Mil.

RaySearch Laboratories AB's quarterly Other Stockholders Equity declined from Sep. 2025 ($98.1 Mil) to Dec. 2025 ($-1.7 Mil) but then increased from Dec. 2025 ($-1.7 Mil) to Mar. 2026 ($111.9 Mil).

RaySearch Laboratories AB's annual Other Stockholders Equity increased from Dec. 2023 ($-0.6 Mil) to Dec. 2024 ($0.1 Mil) but then declined from Dec. 2024 ($0.1 Mil) to Dec. 2025 ($-1.7 Mil).

RaySearch Laboratories AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB Other Stockholders Equity Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.82 -0.23 -0.57 0.06 -1.70

RaySearch Laboratories AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.99 88.91 98.08 -1.70 111.91
RSLBF
90GF Score
RaySearch Laboratories AB RSLBF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $111.9 Mil mean?
RaySearch Laboratories AB (RSLBF) has a Other Stockholders Equity of $111.9 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's Other Stockholders Equity too high?
RaySearch Laboratories AB's current Other Stockholders Equity is $111.9 Mil. Overall, RaySearch Laboratories AB has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Other Stockholders Equity compare to VEEV and BTSG?
RaySearch Laboratories AB's Other Stockholders Equity of $111.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Other Stockholders Equity is $111.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (RSLBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.70, compared to a current price of $24.00 — trading 21.8% above its estimated fair value. The current Other Stockholders Equity is $111.9 Mil. RaySearch Laboratories AB's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For RaySearch Laboratories AB (RSLBF), the current Other Stockholders Equity is $111.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of $24.00 is trading 21.8% above its estimated GF Value™ of $19.70. GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.

Key valuation signals for RSLBF:

  • Other Stockholders Equity: $111.9 Mil
  • GF Value™: $19.70 vs. price of $24.00 (21.8% above fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
90GF Score

Get the complete analysis for RSLBF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.00
Price
$19.70
GF Value